FAKTOR-OPTIONSSCHEIN - MEDTRONIC Stock

Certificat

DE000SQ40ND6

Market Closed - Deutsche Boerse AG 03:48:59 2024-07-12 pm EDT
4.92 EUR +0.20% Intraday chart for FAKTOR-OPTIONSSCHEIN - MEDTRONIC
Current month-5.75%
1 month-20.65%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-12 4.92 +0.20%
24-07-11 4.91 +4.47%
24-07-10 4.7 0.00%
24-07-09 4.7 +1.08%
24-07-08 4.65 -6.25%

Delayed Quote Deutsche Boerse AG

Last update July 12, 2024 at 03:48 pm EDT

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying MEDTRONIC PLC
IssuerLogo Issuer Société Générale Société Générale
WKN SQ40ND
ISINDE000SQ40ND6
Date issued 2022-12-02
Strike 79.06 $
Maturity Unlimited
Parity 1 : 1
Emission price 10.04
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 14.29
Lowest since issue 3.99
Spread 0.01
Spread %0.20%

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
77.95 USD
Average target price
93.52 USD
Spread / Average Target
+19.98%
Consensus